English Abstract
Journal Article
Add like
Add dislike
Add to saved papers

[New psychoactive substances abuse among patients with access to methadone maintenance treatment in Jiangsu province: a case-control study].

Objective: To explore the reasons and factors associated with new psychoactive substances abuse among patients with access to methadone maintenance treatment (MMT). Methods: A well-developed questionnaire and urine tests were used to collect information about demographic characteristics, condition of MMT and drug abuse, family and social support of MMT clients. A 1∶1 matched case-control study was conducted, and conditional logistic regression model was used to identify factors associated with new psychoactive substances abuse. Results: A total of 212 (106 pairs) clients receiving MMT were recruited, and most of them were males (78.3 % , 166/212), married or cohabitant (48.6 % , 103/212) and unemployed (63.2 % , 134/212). The average age of the clients was (45.1±7.2) years. The main types of abused new psychoactive substances were benzodiazepine (62.3 % , 66/106) and methamphetamine (39.6 % , 42/106). The proportion of abusing multi new psychoactive substances was 8.5 % (9/106). Results from multivariate conditional logistic regression analysis indicated that using opioid drug during the past 6 months of MMT treatment might increase the risk of abusing new psychoactive substances ( OR =3.25, 95 %CI : 1.35-7.79), benzodiazepine ( OR =3.25, 95 %CI : 1.11- 9.47) and methamphetamine ( OR =13.31, 95 %CI : 1.12-158.01). Moreover, MMT for more than9 years reduced the risk of abuse of new psychoactive substances ( OR =0.03, 95 %CI : 0.01-0.21), benzodiazepine ( OR =0.02, 95 %CI : 0.00-0.36) and methamphetamine ( OR =0.02, 95 %CI : 0.00-0.69). Conclusion: Less new psychoactive substances abuse might be associated with longer duration of MMT treatment. And inappropriate support from family and friends might increase the risk of abusing new psychoactive substances in MMT clients, especially in clients who used opioid.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app